Age-associated Arterial Dysfunction, Western Diet, and Aerobic Exercise: Role of the Gut Microbiome
1 other identifier
interventional
120
1 country
1
Brief Summary
The risk of developing cardiovascular diseases increases with aging largely due to age-related declines in the function of arteries (arterial dysfunction), which are influenced by common lifestyle factors such as consumption of a "Western" diet and lack of sufficient physical activity; thus, it is important to study how these factors interact to affect artery function. This study will determine whether changes to the gut microbiome (the collection of bacteria and other "microbes" living in the intestinal tract) with aging, Western diet consumption and aerobic exercise influence arterial function, and the biological pathways (mechanisms) involved. Specifically, the investigators will perform a randomized, single-blind, controlled feeding crossover study design (comparing Western diet to non-Western diet consumption) in young and older, exercising and non-exercising healthy adults to determine the time course effects (temporal association) of diet on the gut microbiome and arterial function. Overall, this research has potential to establish the gut microbiome as a possible target for treating/preventing age-related arterial dysfunction and reducing the risk of age-associated cardiovascular diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 1, 2017
CompletedFirst Posted
Study publicly available on registry
November 7, 2017
CompletedStudy Start
First participant enrolled
March 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedOctober 28, 2021
October 1, 2021
3.8 years
November 1, 2017
October 27, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Change in the gut microbiome
Sterile fecal swabs will be collected and analyzed using 16S rRNA sequencing
7 days
Change in endothelial function
Brachial artery flow-mediated dilation
7 days
Change in arterial stiffness
Carotid-femoral pulse wave velocity
7 days
Study Arms (2)
Western diet first
OTHERTo receive Western diet controlled feeding first, followed by non-Western diet controlled feeding
Non-Western diet first
OTHERTo receive non-Western diet controlled feeding first, followed by Western diet controlled feeding
Interventions
high fat (40%), high sugar (25%) and low fiber (15g/day)
low fat (25%), low sugar (15%), high fiber (30g/day)
Eligibility Criteria
You may qualify if:
- Age 18-29 or 60-79 years
- Participating in \< 30 min aerobic exercise \< 2x/wk for \>3 years OR \> 45 min vigorous aerobic exercise \> 4x/wk for \> 3 yrs
- Currently consuming levels of dietary fat intake with the 40th-60th percentile of Americans based on the NHANES survey (29-37% calories from fat)
- Healthy (no clinical disease)
- Body mass index \< 30 kg/m2
- Ankle-brachial blood pressure index \> 0.9
- Total cholesterol \< 240 mg/dl
- Fasting plasma glucose \< 110 mg/dl
- Weight stable in the past 6 months
You may not qualify if:
- Current or past (within 3 months of screening) use of dietary supplements, anti-inflammatory medications, drugs known to affect the gut microbiome (antibiotics, pre/probiotics, antifungals, antivirals, antiparasitics), or gastrointestinal-targeted drugs (proton pump inhibitors, H2 receptor antagonists, laxatives, antidiarrheal medications)
- Current of past (within 5 years) smoking
- Major change in health status in the last 6 months
- Chronic clinical diseases (e.g., inflammatory bowl diseases, cardiovascular disease, diabetes, neurological disorders, dementia or other brain diseases of aging)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Boulder
Boulder, Colorado, 80309, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Douglas R Seals, PhD
University of Colorado, Boulder
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Single-blind
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Distinguished Professor
Study Record Dates
First Submitted
November 1, 2017
First Posted
November 7, 2017
Study Start
March 15, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
October 28, 2021
Record last verified: 2021-10